MHRA approves first COVID-19 antiviral that can be taken at home

“The antiviral Lagevrio (molnupiravir), is “safe and effective” at reducing the risk of hospitalisation or death in people “with mild to moderate COVID-19 who are at increased risk of developing severe disease”, the MHRA announced today (November 4).

Developed by the US drug companies Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics, it is the first antiviral medication for COVID-19 that can be taken as a pill rather than given intravenously” 

Read the full story here;

Leave a Reply

Your email address will not be published. Required fields are marked *